We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Simple Tool Reduces Coronary Angioplasty Complications

By HospiMedica International staff writers
Posted on 01 Dec 2014
A new screening tool calculates a patient's bleeding risk during percutaneous coronary intervention (PCI), based on nine clinical variables. More...


Researchers at Allina Health (Minneapolis, MN, USA) conducted a study to examine the efficacy of a screening tool developed from data collected from the US National Cardiovascular Data Registry (NCDR) Cath-PCI Registry. They first created a data dashboard for all Allina Health cardiac catheterization staff to use before PCI procedures, and held learning sessions about the importance and benefits of using the tool to identify high-risk patients before their procedures, so that strategies to avoid bleeding can be put in place.

They then reviewed data on all patients in the Allina Health system from July 2009 to December 2011 to retrospectively verify the NCDR's screening tool's ability to predict patients with high, intermediate, and low bleeding risks. Data collection and analysis were simplified because the hospitals have a unified electronic medical record and participate in NCDR. The results showed that within one month, more than 75% of patients were being screened before procedures, resulting in a 5.3% decrease in all post-procedure complications, including the need for blood transfusions. The study was published on November 4, 2014, in Circulation: Cardiovascular Quality Outcomes.

“Bleeding from the insertion site from blood thinners used during the procedure is a common complication of PCI, occurring two to six percent of the time. That might not sound serious, but bleeding is associated with adverse events, including death,” said lead author Craig Strauss, MD, MPH, of the Allina health Abbott Northwestern Hospital. “Achieving these improvements should lead to significant reductions including costs associated with hospital readmissions.”

During PCI, a cardiologist feeds a deflated balloon or other device on a catheter from the inguinal femoral artery or radial artery up through blood vessels until they reach the site of blockage in the heart; X-ray imaging is used to guide the catheter threading. At the blockage, the balloon is inflated to open the artery, allowing blood to flow. A stent is often placed at the site of blockage to permanently open the artery.

Related Links:

Allina Health



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.